Search Results
NHS Nightingale Hospital London, London, UK
Search for other papers by Ashley K Clift in
Google Scholar
PubMed
Search for other papers by Andrea Frilling in
Google Scholar
PubMed
Introduction Neuroendocrine neoplasms (NEN) represent a heterogeneous class of tumours that arise from nigh ubiquitously dispersed neuroendocrine cells, which may be stratified into clinically meaningful sub-groups on the basis of their
Maimonides Institute for Biomedical Research of Cordoba (IMIBIC); Reina Sofia University Hospital, Córdoba, Spain
Search for other papers by Aura D Herrera-Martínez in
Google Scholar
PubMed
Search for other papers by Leo J Hofland in
Google Scholar
PubMed
Search for other papers by María A Gálvez Moreno in
Google Scholar
PubMed
Search for other papers by Justo P Castaño in
Google Scholar
PubMed
Search for other papers by Wouter W de Herder in
Google Scholar
PubMed
Search for other papers by Richard A Feelders in
Google Scholar
PubMed
Introduction Neuroendocrine neoplasms (NENs) represent a heterogeneous group of rare neoplasms, which originate from enterochromaffin cells that are located throughout the whole body. NENs located in the gastrointestinal tract and pancreas are
Search for other papers by Maria Chiara Zatelli in
Google Scholar
PubMed
Search for other papers by Elia Guadagno in
Google Scholar
PubMed
Search for other papers by Erika Messina in
Google Scholar
PubMed
Search for other papers by Fabio Lo Calzo in
Google Scholar
PubMed
Search for other papers by Antongiulio Faggiano in
Google Scholar
PubMed
Search for other papers by Annamaria Colao in
Google Scholar
PubMed
Search for other papers by NIKE Group in
Google Scholar
PubMed
Introduction Neuroendocrine neoplasms (NENs) are well known to display a wide heterogeneity as concerns histopathology, clinical presentation, treatment and prognosis. Despite their rarity, NENs have drawn a lot of attention due to the newly
Search for other papers by Corinne Gérard in
Google Scholar
PubMed
Search for other papers by Marie Lagarde in
Google Scholar
PubMed
Search for other papers by Flora Poizat in
Google Scholar
PubMed
Search for other papers by Sandrine Oziel-Taieb in
Google Scholar
PubMed
Search for other papers by Vincent Garcia in
Google Scholar
PubMed
Search for other papers by Catherine Roche in
Google Scholar
PubMed
Search for other papers by Patricia Niccoli in
Google Scholar
PubMed
Molecular Biology Laboratory, Hospital La Conception, AP-HM, Marseille, France
Search for other papers by Anne Barlier in
Google Scholar
PubMed
Search for other papers by David Romano in
Google Scholar
PubMed
Introduction Neuroendocrine neoplasms (NENs) (comprising well-differentiated NENs ((G1 to G3) and poorly differentiated NECs ( Inzani et al. 2018 )) are a heterogeneous group of malignancies with various clinical presentations and evolution
Search for other papers by Jennifer R Eads in
Google Scholar
PubMed
Search for other papers by Thorvardur R Halfdanarson in
Google Scholar
PubMed
Search for other papers by Tim Asmis in
Google Scholar
PubMed
Search for other papers by Andrew M Bellizzi in
Google Scholar
PubMed
Search for other papers by Emily K Bergsland in
Google Scholar
PubMed
Search for other papers by Arvind Dasari in
Google Scholar
PubMed
Search for other papers by Ghassan El-Haddad in
Google Scholar
PubMed
Search for other papers by Michael Frumovitz in
Google Scholar
PubMed
Search for other papers by Joshua Meyer in
Google Scholar
PubMed
Search for other papers by Erik Mittra in
Google Scholar
PubMed
Search for other papers by Sten Myrehaug in
Google Scholar
PubMed
Search for other papers by Eric Nakakura in
Google Scholar
PubMed
Search for other papers by Nitya Raj in
Google Scholar
PubMed
Search for other papers by Heloisa P Soares in
Google Scholar
PubMed
Search for other papers by Brian Untch in
Google Scholar
PubMed
Search for other papers by Namrata Vijayvergia in
Google Scholar
PubMed
Search for other papers by Jennifer A Chan in
Google Scholar
PubMed
Introduction High-grade neuroendocrine neoplasms (NENs) constitute a rare disease entity and account for approximately 10% of all NENs. Given their rarity, there is a paucity of prospective data to guide the optimal diagnosis and management of
Member of the German Cancer Consortium (DKTK), Germany
Search for other papers by Atsuko Kasajima in
Google Scholar
PubMed
Search for other papers by Günter Klöppel in
Google Scholar
PubMed
Introduction Neuroendocrine neoplasms (NENs) arise from various anatomical sites in the body but share basic features. NENs consist of two main families, well-differentiated NENs, also called neuroendocrine tumors (NETs) or carcinoids, and
Search for other papers by Thomas Yang Sun in
Google Scholar
PubMed
Search for other papers by Lan Zhao in
Google Scholar
PubMed
Search for other papers by Paul Van Hummelen in
Google Scholar
PubMed
Search for other papers by Brock Martin in
Google Scholar
PubMed
Search for other papers by Kathleen Hornbacker in
Google Scholar
PubMed
Search for other papers by HoJoon Lee in
Google Scholar
PubMed
Division of Biostatistics, Department of Epidemiology and Public Health, Albert Einstein College of Medicine, Bronx, New York, USA
Search for other papers by Li C Xia in
Google Scholar
PubMed
Search for other papers by Sukhmani K Padda in
Google Scholar
PubMed
Stanford Genome Technology Center, Stanford, California, USA
Search for other papers by Hanlee P Ji in
Google Scholar
PubMed
Search for other papers by Pamela Kunz in
Google Scholar
PubMed
Introduction Neuroendocrine neoplasms (NENs) commonly originate from the gastroenteropancreatic (GEP) organs and the lungs but can also arise from most other organs in the body, including the genitourinary tract, head and neck, the gynecologic
Search for other papers by Maria Chiara Zatelli in
Google Scholar
PubMed
Search for other papers by Erika Maria Grossrubatscher in
Google Scholar
PubMed
Search for other papers by Elia Guadagno in
Google Scholar
PubMed
Search for other papers by Concetta Sciammarella in
Google Scholar
PubMed
Search for other papers by Antongiulio Faggiano in
Google Scholar
PubMed
Search for other papers by Annamaria Colao in
Google Scholar
PubMed
Introduction Neuroendocrine neoplasms (NENs) are heterogeneous tumors with widely different behavior and prognosis, that to date had been related mainly to the grade of neuroendocrine differentiation as well as the proliferative attitude of
Ospedale Policlinico San Martino IRCCS, Genova, Italy
Search for other papers by Federica Grillo in
Google Scholar
PubMed
Search for other papers by Tullio Florio in
Google Scholar
PubMed
Search for other papers by Francesco Ferraù in
Google Scholar
PubMed
Search for other papers by Elda Kara in
Google Scholar
PubMed
Search for other papers by Giuseppe Fanciulli in
Google Scholar
PubMed
Search for other papers by Antongiulio Faggiano in
Google Scholar
PubMed
Search for other papers by Annamaria Colao in
Google Scholar
PubMed
Search for other papers by NIKE Group in
Google Scholar
PubMed
Introduction Neuroendocrine neoplasms (NENs) are a heterogeneous family of neoplasms originating from neuroendocrine cells dispersed in different organs, most frequently in the digestive system and in the lungs. The last few decades have
Search for other papers by Wiebke Werner in
Google Scholar
PubMed
Search for other papers by Katharina Detjen in
Google Scholar
PubMed
Search for other papers by Alix Bruneau in
Google Scholar
PubMed
Search for other papers by Isabella Lurje in
Google Scholar
PubMed
Search for other papers by Natalie Nestel in
Google Scholar
PubMed
Search for other papers by Henning Jann in
Google Scholar
PubMed
Search for other papers by Frank Tacke in
Google Scholar
PubMed
Search for other papers by Bertram Wiedenmann in
Google Scholar
PubMed
Clinic for Gastroenterology, Hepatology and Infectious Diseases, University Hospital Düsseldorf, Medical Faculty of Heinrich Heine, University Düsseldorf, Düsseldorf, Germany
Search for other papers by Christoph Roderburg in
Google Scholar
PubMed
Search for other papers by Linda Hammerich in
Google Scholar
PubMed
Introduction Gastroenteropancreatic neuroendocrine neoplasms (GEP-NEN) account for approximately two-thirds of all neuroendocrine malignancies ( Kaliszewski et al. 2022 ). The current World Health Organization (WHO) classification system